A Painful PGx Codeine Controversy | Pain Pod
- 22m
- Transcript
Summary
Written by a model from the transcript; not yet reviewed.
This episode explores the ongoing controversy surrounding a widely cited 2006 case report in the Lancet, which linked a newborn infant's fatal morphine toxicity to maternal codeine ingestion during breastfeeding combined with a CYP450 2D6 ultra-rapid metabolizer phenotype. The host examines subsequent 2020 journal retractions, investigative reporting by the New Yorker in early 2026, and a fresh Lancet expression of concern that prompted a formal investigation into data falsification and ethical issues. Through this case study, the host unpacks the critical distinction between correlation and causation in clinical toxicology, questioning whether breast milk transfer alone accounts for the postmortem findings and discussing alternative hypotheses such as direct administration.
- Clinicians must carefully distinguish between establishing a pharmacogenetic observation and proving a direct causal link to a patient outcome. 19:06
- Pharmacogenetic mechanisms that are theoretically plausible do not automatically explain every clinical event or validate a single study's conclusions. 8:06
- Postmortem toxicology findings must be rigorously evaluated for internal consistency, including the route of exposure and presence of unexpected substances. 10:12
- Healthcare professionals should critically examine historical case reports and not automatically shift practice based on questionable or heavily disputed evidence. 2:07
Chapters
- 0:05Podcast Intro and Host Overview
The hosts introduce the Pain Pod, its focus on pain management, and the host Dr. Mark Grofely.
- 1:58Introducing the Codeine Controversy
The episode announces a deep dive into a controversial pharmacogenetic case involving codeine and a newborn infant.
- 7:07Genetic Findings and Breast Milk Exposure
The mother’s CYP2D6 ultra‑rapid metabolizer status and the resulting high morphine levels in breast milk are explained.
- 8:23Critiques and Retractions (2020‑2026)
Independent analyses, journal retractions, and the Lancet’s expression of concern are discussed, highlighting doubts about the original conclusions.
- 11:13Alternative Explanations and Toxicology Findings
Evidence suggesting direct codeine administration to the infant and inconsistencies in toxicology data are explored.
- 12:00Closing Remarks and Future Episodes
The host invites listeners to future discussions on PGx and pain, and thanks the audience for tuning in.
- 19:45Clinical Take‑aways and Evidence Limits
Listeners are urged to recognize the difference between pharmacogenetic observation and causal inference, and to apply cautious interpretation in practice.
Highlights
- 2:30
The Lancet Expression of Concerndata
The Lancet issued an expression of concern regarding the original 2006 case study, following investigative journalism and fresh allegations of data falsification and authorship problems.
- 3:59
The foundational case report described a 13-day-old breastfed infant who died with an elevated postmortem morphine concentration after his mother used codeine acetaminophen.
- 7:34
Proposed Chain of Causationinsight
The proposed pharmacological pathway suggested that maternal ultra-rapid metabolism increased codeine-to-morphine conversion, leading to high breast milk morphine and neonatal toxicity.
- 8:28
Subsequent Journal Retractionsdata
In 2020, Canadian Family Physician and the Canadian Pharmacists Journal formally retracted articles based on the case after independent reviewers cited unreliable toxicology and implausible mechanisms.
- 10:12
Codeine Found Without Morphineinsight
Forensic testing revealed codeine but not morphine in the infant's stomach contents, suggesting alternative explanations such as direct administration of the medication.
- 13:04
Opioid Side Effect Pearlstrategy
Hydrophilic opioids like codeine can facilitate constipation even at lower dosages compared to their higher-dose counterparts or lipophilic opioids.
- 18:42
Observation Versus Causal Conclusioninsight
The host emphasizes that proving a mother is an ultra-rapid metabolizer is a pharmacogenetic observation, which is distinct from proving that phenotype caused the infant's death.
Quotes
“The OG case should probably no longer be presented as an uncomplicated example of 2D6 ultra rapid metabolism causing fatal morphine poisoning through breast milk.”
Unnamed speaker · 19:45 “Know the pharmacology, know the genotype, know the tox, know that toxicology, know the limits of the evidence.”
Unnamed speaker · 20:43 “The very small amount of opioid normally transferred into the breast milk.”
Unnamed speaker · 9:47 “The postmortem examination revealed that the stomach had no abnormalities or obstructions or anything like that, yet it contained two ml's of white curdled material.”
Unnamed speaker · 10:54
About this episode
Investigative reports, mount up! It’s time to question the longstanding pharmacogenic concerns for some prescription opioid pain medications! Come one, come all, to the Pain Pod!!! P. S. Want to contribute or hear about a pain pearl of your own? Message Pain Guy on www.painguy.us to directly reach Mark and have your voice heard! Pain Guy• www.painguy.usCodeine Guidance in Doubt After Calls for Retraction of Pivotal Lancet Study• http://doi.org/10.1136/bmj.s4982006 Original Lancet Case Study• https://pubmed.ncbi.nlm.nih.gov/16920476/2020 The Implausibility of Neonatal Opioid Toxicity from Breastfeeding• https://pubmed.ncbi.nlm.nih.gov/32378749/2026 New Yorker Investigation• https://www.newyorker.com/magazine/2026/02/02/did-a-celebrated-researcher-obscure-a-fatal-poisoning2026 Lancet “Expression of Concern”• https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(26)00245-X/fulltext
Transcript
3,328 words · 3 speakers
Topics
- morphine
- Lancet
- 2D6
- New Yorker
- T3
- postmortem morphine concentration
- codeine acetaminophen
- Canadian Family Physician
- Canadian Pharmacists Journal
- Toronto's Hospital for Sick Children
Page updated · transcript and summary are machine-generated